Kang Shijun

Prof. Kang has over 30 years of clinical experience. Two decades ago, he pioneered the clinical application of radiofrequency ablation and PET-CT technology in lung tumor research and published internationally leading findings. He has conducted postdoctoral and senior visiting scholar work at the University of Chicago and the University of Illinois in the United States. He specializes in integrating targeted therapy, immunotherapy, and minimally invasive interventions with traditional chemotherapy and radiotherapy for the treatment of various common malignant tumors. Prof. Kang has extensive diagnostic and therapeutic experience in managing lung cancer, breast cancer, esophageal cancer, hepatobiliary-pancreatic malignancies, and head and neck tumors.

• Chair, Lung Cancer Committee, Guangzhou AntiCancer Association;
• Deputy Chair, Thoracic Oncology Group, Oncology Society, Guangdong Provincial Medical Association;
• Standing Committee Member, Senior Experts Council, Guangdong Clinical Medicine Association